The study of the permeability of the blood-brain barrier for new neurotropic peptide drugs by V. P. Zherdev, S. S. Boyko, R. V. Shevchenko

Connect to this object online.

The Role of pharmacokinetics and biopharmaceutical investigations in the creation of a new dipeptide drugs (experimental investigation) by V. P. Zherdev, S. S. Boyko, R. V. Shevchenko, T. A. Gudasheva

Connect to this object online.

The role of studies of interspecies differences pharmacokinetics in the creation of new peptide drugs by V. P. Zherdev, S. S. Boyko, R. V. Shevchenko, P. O. Bochkov, O. V. Gribakina, S. Yu. Raskin

Connect to this object online.

Pharmacokinetic relationships in psychotropic drugs effects by G. B. Kolyvanov, A. A. Litvin, R. V. Shevchenko, S. Yu. Raskin, P. O. Bochkov, V. P. Zherdev

Connect to this object online.

Absolute bioavailability of a substance with cardioprotective activity (ALM-802) in rats by G. B. Kolyvanov, P. O. Bochkov, A. A. Litvin, R. V. Shevchenko, A. L. Podolko, V. P. Zherdev

Connect to this object online.

Determination of a novel anticonvulsant drug GIZh-290 in rat plasma by liquid chromatography-tandem mass spectrometry by P. O. Bochkov, I. P. Khrustova, A. A. Litvin, G. B. Kolyvanov, R. V. Shevchenko, V. P. Zherdev

Connect to this object online.

Tropoxine in the effective dose does not affect on activity of CYP2С9 and CYP1А2 isoforms of cytochrome P450 in rats by V. P. Zherdev, G. B. Kolyvanov, A. A. Litvin, O. G. Grybakina, P. O. Bochkov, R. V. Shevchenko

Connect to this object online.

Pharmacokinetic comparative study of tropoxine metabolite in miscellaneous animal species and humans by V. P. Zherdev, G. B. Kolyvanov, A. A. Litvin, P. O. Bochkov, R. V. Shevchenko, O. G. Grybakina, T. S. Ganshina

Connect to this object online.

Development and validation of the quantification of GIZH-298, possessing in the rat blood plasma by HPLC-UF by O. G. Gribakina, R. V. Shevchenko, G. B. Kolyvanov, A. A. Litvin, P. O. Bochkov, S. S. Boyko, V. P. Zherdev

Connect to this object online.

Study of the effect of anxiolytic GML-1 on the activity of cytochrome CYP2C9 and CYP1A2 isoforms by O. G. Gribakina, R. V. Shevchenko, P. O. Bochkov, A. A. Novitskiy, A. A. Litvin, G. B. Kolyvanov, V. P. Zherdev

Connect to this object online.

The pharmacokinetics of the injectable dosage form of GK-2 in rabbits by R. V. Shevchenko, A. A. Litvin, G. B. Kolyvanov, P. O. Bochkov, O. G. Gribakina, A. A. Novitskiy, V. P. Zherdev

Connect to this object online.

HPLC-MS method development and validation for simultaneous quantitation of GZK-111 and CPG compounds in rat plasma by A. L. Podolko, P. O. Bochkov, G. B. Kolyvanov, A. A. Litvin, O. G. Gribakina, R. V. Shevchenko, V. P. Zherdev

Connect to this object online.

Pharmacokinetics of dipeptide mimetic BDNF GSB-106 in rats by V. P. Zherdev, G. B. Kolyvanov, A. A. Litvin, P. O. Bochkov, O. G. Gribakina, R. V. Shevchenko, A. V. Tarasyuk, T. A. Gudasheva

Connect to this object online.

Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thro... by l. V. Fedina, i. N. Sychev, K. V. Mirzaev, A. V. Vardanyan, S. V. Glagolev, A. A. Kachanova, P. O. Bochkov, R. V. Shevchenko, S. N. Tuchkova, I. V. Sychev, S. P. Abdullaev, D A. Sychev

Connect to this object online.

Pharmacokinetics of dipeptide anxiolytic GB-115 after oral administration in different animals species and humans by S. Yu. Raskin, G. B. Kolyvanov, A. A. Litvin, P. O. Bochkov, R. V. Shevchenko, V. V. Smirnov, O. G. Grybakina, A. A. Novitskyi, V. P. Zherdev, L. G. Kolik, T. A. Gudasheva, N. Yu. Ivashkina

Connect to this object online.